Geode Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-203,930
| Closed | -$650K | – | 5119 |
|
|
2022
Q2 | $650K | Buy |
203,930
+1,114
| +0.5% | +$4.34K | ﹤0.01% | 3619 |
|
|
2022
Q1 | $866K | Sell |
202,816
-81,054
| -29% | -$353K | ﹤0.01% | 3679 |
|
|
2021
Q4 | $1.32M | Buy |
283,870
+8,454
| +3% | +$35.2K | ﹤0.01% | 3572 |
|
|
2021
Q3 | $1.1M | Buy |
275,416
+1,055
| +0.4% | +$4.19K | ﹤0.01% | 3626 |
|
|
2021
Q2 | $1.17M | Sell |
274,361
-142,226
| -34% | -$609K | ﹤0.01% | 3514 |
|
|
2021
Q1 | $1.77M | Buy |
416,587
+14,998
| +4% | +$82.6K | ﹤0.01% | 3310 |
|
|
2020
Q4 | $1.56M | Buy |
401,589
+8,826
| +2% | +$37.7K | ﹤0.01% | 3207 |
|
|
2020
Q3 | $1.58M | Sell |
392,763
-4,101
| -1% | -$17K | ﹤0.01% | 3002 |
|
|
2020
Q2 | $1.69M | Buy |
396,864
+81,586
| +26% | +$497K | ﹤0.01% | 2930 |
|
|
2020
Q1 | $1.32M | Sell |
315,278
-34,983
| -10% | -$221K | ﹤0.01% | 2895 |
|
|
2019
Q4 | $1.38M | Buy |
350,261
+8,581
| +3% | +$50.7K | ﹤0.01% | 3156 |
|
|
2019
Q3 | $3.01M | Buy |
341,680
+25,259
| +8% | +$239K | ﹤0.01% | 2691 |
|
|
2019
Q2 | $2.93M | Buy |
316,421
+56,148
| +22% | +$423K | ﹤0.01% | 2712 |
|
|
2019
Q1 | $1.67M | Buy |
260,273
+32,789
| +14% | +$214K | ﹤0.01% | 2957 |
|
|
2018
Q4 | $2.15M | Buy |
227,484
+7,370
| +3% | +$111K | ﹤0.01% | 2734 |
|
|
2018
Q3 | $4.43M | Buy |
220,114
+15,457
| +8% | +$404K | ﹤0.01% | 2427 |
|
|
2018
Q2 | $5.97M | Buy |
204,657
+33,815
| +20% | +$1.04M | ﹤0.01% | 2222 |
|
|
2018
Q1 | $5.09M | Buy |
170,842
+14,888
| +10% | +$480K | ﹤0.01% | 2225 |
|
|
2017
Q4 | $5.02M | Buy |
155,954
+6,375
| +4% | +$208K | ﹤0.01% | 2213 |
|
|
2017
Q3 | $5.2M | Buy |
149,579
+9,217
| +7% | +$296K | ﹤0.01% | 2184 |
|
|
2017
Q2 | $4.18M | Buy |
140,362
+30,429
| +28% | +$872K | ﹤0.01% | 2272 |
|
|
2017
Q1 | $3.28M | Buy |
109,933
+4,611
| +4% | +$118K | ﹤0.01% | 2371 |
|
|
2016
Q4 | $1.85M | Buy |
105,322
+6,211
| +6% | +$119K | ﹤0.01% | 2676 |
|
|
2016
Q3 | $2.36M | Buy |
99,111
+2,912
| +3% | +$54.9K | ﹤0.01% | 2454 |
|
|
2016
Q2 | $1.54M | Buy |
96,199
+1,117
| +1% | +$20K | ﹤0.01% | 2656 |
|
|
2016
Q1 | $1.99K | Buy |
95,082
+7,582
| +9% | +$135K | ﹤0.01% | 2466 |
|
|
2015
Q4 | $2.36M | Sell |
87,500
-6,569
| -7% | -$179K | ﹤0.01% | 2358 |
|
|
2015
Q3 | $2.61M | Buy |
94,069
+26,824
| +40% | +$845K | ﹤0.01% | 2256 |
|
|
2015
Q2 | $1.65M | Buy |
67,245
+7,450
| +12% | +$154K | ﹤0.01% | 2614 |
|
|
2015
Q1 | $1.09M | Buy |
59,795
+2,924
| +5% | +$59.3K | ﹤0.01% | 2831 |
|
|
2014
Q4 | $1.05M | Buy |
56,871
+21,390
| +60% | +$254K | ﹤0.01% | 2809 |
|
|
2014
Q3 | $340K | Buy |
35,481
+15,443
| +77% | +$154K | ﹤0.01% | 3341 |
|
|
2014
Q2 | $183K | Buy |
20,038
+8,774
| +78% | +$80.1K | ﹤0.01% | 3542 |
|
|
2014
Q1 | $121K | Buy |
+11,264
| New | +$111K | ﹤0.01% | 3627 |
|
Geode Capital Management's LJPC Position: Q3 2022 in Review
Geode Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 203,930 shares — an estimated $650K sold.
Geode Capital Management first reported a position in LJPC in Q1 2014 and held it in 34 quarters. The position peaked at $5.97M in Q2 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Geode Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Geode Capital Management sold 203,930 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $650K.
- Geode Capital Management first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 34 quarters.
- Geode Capital Management's La Jolla Pharmaceutical Company position peaked at $5.97M in Q2 2018.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.